Cingulate, Inc. (CING)
5.30
+0.11
(+2.12%)
USD |
NASDAQ |
Sep 09, 09:57
Cingulate 1 Year Total Returns (Daily) : 38.40% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 38.40% |
| September 04, 2026 | 34.56% |
| September 03, 2026 | 41.08% |
| September 02, 2026 | 38.07% |
| September 01, 2026 | 28.07% |
| August 31, 2026 | 29.57% |
| August 28, 2026 | 35.15% |
| August 27, 2026 | 30.14% |
| August 26, 2026 | 25.58% |
| August 25, 2026 | 39.60% |
| August 24, 2026 | 35.56% |
| August 21, 2026 | 39.10% |
| August 20, 2026 | 36.67% |
| August 19, 2026 | 40.16% |
| August 18, 2026 | 25.00% |
| August 17, 2026 | 28.96% |
| August 14, 2026 | 23.24% |
| August 13, 2026 | 35.60% |
| August 12, 2026 | 27.38% |
| August 11, 2026 | 28.40% |
| August 10, 2026 | 25.90% |
| August 07, 2026 | 26.84% |
| August 06, 2026 | 11.73% |
| August 05, 2026 | -8.86% |
| August 04, 2026 | -12.66% |
| Date | Value |
|---|---|
| August 03, 2026 | -5.29% |
| July 31, 2026 | -7.53% |
| July 30, 2026 | -8.29% |
| July 29, 2026 | -12.31% |
| July 28, 2026 | -13.22% |
| July 27, 2026 | -17.82% |
| July 24, 2026 | -13.59% |
| July 23, 2026 | -13.11% |
| July 22, 2026 | -15.53% |
| July 21, 2026 | -15.64% |
| July 20, 2026 | -11.80% |
| July 17, 2026 | -5.61% |
| July 16, 2026 | -6.14% |
| July 15, 2026 | 1.55% |
| July 14, 2026 | -0.42% |
| July 13, 2026 | 7.59% |
| July 10, 2026 | 10.84% |
| July 09, 2026 | 9.27% |
| July 08, 2026 | 7.32% |
| July 07, 2026 | 15.16% |
| July 06, 2026 | 23.83% |
| July 02, 2026 | 23.96% |
| July 01, 2026 | 42.27% |
| June 30, 2026 | 34.40% |
| June 29, 2026 | 31.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ANI Pharmaceuticals, Inc. | -26.23% |
| Corcept Therapeutics, Inc. | 60.02% |
| Veru, Inc. | -23.44% |
| Johnson & Johnson | 54.48% |
| Eli Lilly & Co. | 53.12% |